Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Jefferies analyst Young Li initiated coverage on RxSight, Inc. (NASDAQ:RXST) with a Buy rating and announced a price target of $72. RxSight shares closed at $50.25 on Monday. See how other analysts view this stock. Guggenheim analyst Curry Baker initiated…
